Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 109, Issue 7, Pages 1755-1759
Publisher
Springer Nature
Online
2013-09-06
DOI
10.1038/bjc.2013.522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC)
- (2013) Michela de Martino et al. BJU INTERNATIONAL
- Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
- (2013) J Szkandera et al. BRITISH JOURNAL OF CANCER
- Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
- (2013) M Pichler et al. BRITISH JOURNAL OF CANCER
- Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort
- (2013) Roberto Iacovelli et al. EUROPEAN JOURNAL OF CANCER
- Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy
- (2013) Minoru Kobayashi et al. MEDICAL ONCOLOGY
- Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients
- (2012) Sandra Steffens et al. BMC CANCER
- Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity
- (2012) M. Beyrau et al. Open Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma
- (2011) Yoshio Ohno et al. JOURNAL OF UROLOGY
- Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
- (2010) S. Patil et al. ANNALS OF ONCOLOGY
- Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
- (2010) Xin An et al. BIOMARKERS
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
- (2010) S. C. H. Kao et al. CLINICAL CANCER RESEARCH
- EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
- (2010) Börje Ljungberg et al. EUROPEAN UROLOGY
- Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma
- (2010) Yoshio Ohno et al. JOURNAL OF UROLOGY
- Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
- (2009) Yoji Kishi et al. ANNALS OF SURGICAL ONCOLOGY
- EORTC-GU group expert opinion on metastatic renal cell cancer
- (2009) Theo M. de Reijke et al. EUROPEAN JOURNAL OF CANCER
- Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
- (2009) Hanne Krogh Jensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
- (2008) HanByoul Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
- (2008) Khaled M. Sarraf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma
- (2008) D. Gomez et al. WORLD JOURNAL OF SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now